Literature DB >> 655704

Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex.

L J Moberg, H Sugiyama.   

Abstract

Type A botulinum neurotoxin was purified from toxic crystals by adsorption to p-aminophenyl-beta-D-thiogalactopyranoside coupled to CH-Sepharose 4B. At pH 6.3, the toxic complex was held by the binding between the ligand and the hemagglutinin of the complex; the toxin is eluted selectively by dissociating the complex with buffer-saline of pH 7.9. The single-step affinity chromatography recovered 50 to 60% of applied toxicity as preparations of greater than 99% purity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 655704      PMCID: PMC242946          DOI: 10.1128/aem.35.5.878-880.1978

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  10 in total

1.  Studies on immunity to toxins of Clostridium botulinum. I. A simplified procedure for isolation of type A toxin.

Authors:  J T DUFF; G G WRIGHT; J KLERER; D E MOORE; R H BIBLER
Journal:  J Bacteriol       Date:  1957-01       Impact factor: 3.490

2.  Comparative sizes of type A and B botulinum neurotoxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Toxicon       Date:  1977       Impact factor: 3.033

3.  Inhibition of Clostridium botulinum types A and B hemagglutinins by sugars.

Authors:  B R DasGupta; H Sugiyama
Journal:  Can J Microbiol       Date:  1977-09       Impact factor: 2.419

4.  Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins.

Authors:  P Balding; E R Gold; D A Boroff; T A Roberts
Journal:  Immunology       Date:  1973-11       Impact factor: 7.397

5.  Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin.

Authors:  H Sugiyama; I Oishi; B R Dasgupta
Journal:  Appl Microbiol       Date:  1974-02

6.  The role of sulfhydryl groups in the activity of type A botulinum toxin.

Authors:  J Knox; W P Brown; L Spero
Journal:  Biochim Biophys Acta       Date:  1970-08-21

7.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

8.  Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.

Authors:  B R Dasgupta; D A Boroff; E Rothstein
Journal:  Biochem Biophys Res Commun       Date:  1966-03-22       Impact factor: 3.575

9.  Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.

Authors:  H Sugiyama; L J Moberg; S L Messer
Journal:  Appl Environ Microbiol       Date:  1977-04       Impact factor: 4.792

10.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

  10 in total
  16 in total

1.  Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

Authors:  E Somers; B R DasGupta
Journal:  J Protein Chem       Date:  1991-08

2.  Activity of botulinum neurotoxin type D (strain 1873) in human neurons.

Authors:  Sabine Pellett; William H Tepp; Jacob M Scherf; Christina L Pier; Eric A Johnson
Journal:  Toxicon       Date:  2015-04-30       Impact factor: 3.033

3.  Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species.

Authors:  F Chen; G M Kuziemko; R C Stevens
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Botulinum toxin type A blocks the morphological changes induced by chemical stimulation on the presynaptic membrane of Torpedo synaptosomes.

Authors:  J Marsal; G Egea; C Solsona; X Rabasseda; J Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord.

Authors:  H Bigalke; I Heller; B Bizzini; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

Review 6.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

7.  Nature of intracellular type A botulinum neurotoxin.

Authors:  E P Krysinski; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1981-03       Impact factor: 4.792

8.  Inhibition of synaptosomal choline uptake by tetanus and botulinum A toxin. Partial dissociation of fixation and effect of tetanus toxin.

Authors:  E Habermann; H Bigalke; I Heller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

9.  Botulinum toxin inhibits quantal acetylcholine release and energy metabolism in the Torpedo electric organ.

Authors:  Y Dunant; J E Esquerda; F Loctin; J Marsal; D Muller
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

10.  Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals.

Authors:  M Gansel; R Penner; F Dreyer
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.